IRIX / Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates

MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical p more_horizontal

IRIDEX Corporation (NASDAQ:IRIX ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Philip Taylor - Gilmartin Group Dav more_horizontal

Iridex (IRIX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.14 more_horizontal

Iridex (IRIX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.15 more_horizontal

IRIDEX Corporation (NASDAQ:IRIX ) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants Philip Taylor - Investor Relations, G more_horizontal

Iridex (IRIX) delivered earnings and revenue surprises of 36.36% and 0.20%, respectively, for the quarter ended December 2022. Do the numbers hold clu more_horizontal

IRIDEX Corporation (NASDAQ:IRIX ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants David Bruce - Chief Executive Offi more_horizontal

The stock price of IRIDEX (IRIX) fell by 8.58% in the previous trading session. This is why. more_horizontal